Merck slashed its profit forecast as acquisition costs piled up, but it beat on revenue

The pharma giant now expects adjusted earnings of $2.66 to $2.76 per share, down from a prior range of $5.04 to $5.16

Caterpillar raised its revenue growth forecast after beating second-quarter profit estimates on Tuesday, benefiting from a buildout of AI data centers that has spurred demand for its power-generation and construction equipment.

Merck cut its profit guidance due to a charge tied to its acquisition of biotech company Terns Pharmaceuticals.

HBM Nigeria Plc, formerly Lafarge Africa, announced a 57% profit growth and 31% revenue increase in H1 2026, driven by operational efficiency and strategic